Pfizer Europe Ma Eeig
SpainAll drugs from this manufacturer
-
It is an antifungal medication used to treat serious fungal infections (such as aspergillosis, candidemia, and other infections caused by Scedosporium sp. or Fusarium sp.) that may be life-threatening. It is also used to prevent fungal infections in patients at high risk who have received a bone marrow transplant.
Dosage form: powder for solution for infusion
Active substance Dosage voriconazole 200 mg -
It is an antifungal medication used to treat serious fungal infections, such as invasive aspergillosis, candidemia, and other infections caused by Scedosporium sp or Fusarium sp fungi. It is also used to prevent fungal infections in patients who have received a bone marrow transplant and are at high risk.
Dosage form: powder for preparation of oral suspension
Active substance Dosage voriconazole 40 mg -
It is an antifungal medication used to treat serious infections caused by fungi (such as aspergillosis, candidemia, or infections caused by Scedosporium sp and Fusarium sp) in adults and children over 2 years of age. It is also used to prevent fungal infections in patients who have undergone high-risk bone marrow transplantation.
Dosage form: tablets, film-coated
Active substance Dosage voriconazole 50 mg -
It is used to treat adults with a type of lung cancer called non-small cell lung cancer, provided that tests have shown the cancer has certain mutations in the EGFR gene and has spread to the other lung or other organs.
Dosage form: tablets, film-coated
Active substance Dosage dacomitinib monohydrate 15.576 mg -
It is used to treat adults with a type of lung cancer called non-small cell lung cancer, provided that tests have shown the cancer has certain mutations in a gene called EGFR and has spread to the other lung or other organs.
Dosage form: tablets, film-coated
Active substance Dosage dacomitinib monohydrate 31.153 mg -
It is used to treat adults with a type of lung cancer called non-small cell lung cancer, provided that tests have shown the cancer has certain mutations in the EGFR gene and has spread to the other lung or to other organs.
Dosage form: tablets, film-coated
Active substance Dosage dacomitinib monohydrate 46.729 mg -
It is used in adults to treat migraine attacks once they have started and to prevent these attacks from occurring.
Dosage form: powder for preparation of oral solution
Active substance Dosage rimegepant sulfate 85,65 mg -
It is used to treat transthyretin amyloidosis in adult patients with heart involvement (symptomatic cardiomyopathy). It helps prevent the TTR protein from breaking down and forming amyloid.
Dosage form: capsules, soft gelatin
Active substance Dosage taflamidis 61 mg -
It is used to treat transthyretin amyloidosis in adults with nerve involvement, in order to delay the progression of the disease.
Dosage form: capsules, soft gelatin
Active substance Dosage tafamidis meglumine 20 mg -
What happens if I miss a dose?:
Dosage form: capsules, granules for opening
Active substance Dosage crizotinib 150 mg -
It is used to treat adults with a type of non-small cell lung cancer that has an ALK or ROS1 gene alteration. It is also prescribed to children and adolescents (from 1 to less than 18 years old) to treat anaplastic large cell lymphoma (ALCL) or inflammatory myofibroblastic tumor (IMT) with ALK gene defects.
Dosage form: capsules, granules for opening
Active substance Dosage crizotinib 20 mg -
It is used to treat adults with a type of non-small cell lung cancer that has an ALK or ROS1 gene alteration. It is also prescribed to children and adolescents to treat anaplastic large cell lymphoma (ALCL) or inflammatory myofibroblastic tumor (IMT) with ALK gene defects.
Dosage form: capsules, hard
Active substance Dosage crizotinib 200,00 mg -
It is used to treat adults with a type of non-small cell lung cancer that has an ALK or ROS1 gene alteration. It is also prescribed to children and adolescents with anaplastic large cell lymphoma (ALCL) or inflammatory myofibroblastic tumor (IMT) that present with an ALK gene defect.
Dosage form: capsules, hard
Active substance Dosage crizotinib 250,00 mg -
It is used to treat adults with a type of non-small cell lung cancer that has an ALK or ROS1 gene alteration. It is also prescribed to children and adolescents to treat anaplastic large cell lymphoma (ALCL) or inflammatory myofibroblastic tumor (IMT) with ALK gene defects.
Dosage form: capsules, granules for opening
Active substance Dosage crizotinib 50 mg -
It is used to treat active polyarticular juvenile idiopathic arthritis and juvenile psoriatic arthritis in patients 2 years of age or older. It may be taken alone or in combination with methotrexate.
Dosage form: solution, oral
Active substance Dosage tofacitinib citrate 1,62 mg -
It is used to treat various inflammatory diseases such as rheumatoid arthritis, psoriatic arthritis, ulcerative colitis, ankylosing spondylitis, and juvenile idiopathic arthritis (both polyarticular and psoriatic).
Dosage form: tablets, film-coated
Active substance Dosage tofacitinib citrate 16,155 mg -
It is used to treat inflammatory diseases such as rheumatoid arthritis (in adults with moderate to severe cases), psoriatic arthritis, and ankylosing spondylitis (inflammation of the spine).
Dosage form: tablets, prolonged-release
Active substance Dosage tofacitinib citrate 17,77 mg -
It is used to treat inflammatory diseases such as rheumatoid arthritis, psoriatic arthritis, ulcerative colitis, ankylosing spondylitis, polyarticular juvenile idiopathic arthritis, and juvenile psoriatic arthritis.
Dosage form: tablets, film-coated
Active substance Dosage tofacitinib citrate 8,078 mg -
It is used to treat adult patients with various types of advanced cancer, including colorectal cancer (colon or rectum), metastatic breast cancer, advanced non-small cell lung cancer, kidney cancer, epithelial ovarian, Fallopian tube, or primary peritoneal cancer, and persistent, recurrent, or metastatic cervical cancer.
Dosage form: solution for infusion, concentrate
Active substance Dosage bevacizumab 100 mg -
It is used to treat adult patients with various types of advanced cancer, including colorectal cancer (colon or rectum), metastatic breast cancer, advanced non-small cell lung cancer, kidney cancer, epithelial ovarian, Fallopian tube, or primary peritoneal cancer, and persistent, recurrent, or metastatic cervical cancer.
Dosage form: solution for infusion, concentrate
Active substance Dosage bevacizumab 400 mg